Sinofert Holdings Lt : Take benefit from double bottom
|
07/10/2012 | 11:32am
Opinion : Bullish above 1.1 HKD Target price : 1.7 HKD Stop loss: 1.1 HKD
|
STOCK EXCHANGE OF HONG KONG Chemicals - Agricultural |
Sinofert Holdings is the largest comprehensive fertilizer enterprise in China, with a vertically integrated business model which encompasses production, procurement, distribution of various fertilizer products and other related services.
Sinofert Holdings has a low valuation, suggesting a continuation of prices above the significant technical levels being tested.
According to Thomson Reuters consensus from the latest estimates of analysts, the share is trading, on the basis of the current price, 5.94 and 7.76 times the expected results for the current year and the following year. In terms of enterprise value, that is to say the capitalization of the group plus net debt, for a price of 1.35 HKD, the company is worth 0.37 times its sales. Except in case of strong downward revisions of earnings estimates, these low valuation levels theoretically limit the potential fallback.
Although the trend appears bearish in the long term, the potential drop is limited by the significant levels located at HKD 1.1. The extended test of this support area in the recent weeks reinforces its strength and could facilitate a technical rebound. Furthermore, a double bottom is forming in daily data.
Considering these elements, the timing seems appropriate to buy the share. We will benefit from the support to anticipate a return at HKD 1.7. This position will be reduced near the first goal but partially preserved because in case of crossing of this resistance, it would help to set a more ambitious target.
|
|
Copyright (c) 2013 4-Traders.com |
Disclaimer: 4-traders.com is a website published by SURPERFORMANCE SAS. Surperformance or 4-traders.com is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and 4-traders.com services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.
|
|
|
|
|
Valuation |
2013e |
2014e |
|
PER (Price / EPS)
|
8,31x |
7,32x |
|
Capitalization / Revenue
|
0,20x |
0,19x |
|
EV / Revenue
|
0,29x |
0,28x |
|
EV / EBITDA
|
8,12x |
7,37x |
|
Yield (DPS / Price)
|
2,19% |
2,13% |
| Profitability |
2013e |
2014e |
|
Operating Margin (EBIT / Sales)
|
2,85% |
3,03% |
|
operating laverage (Delta EBIT / Delta Sales)
|
9,53x |
2,85x |
|
Net Margin (Net Profit / Revenue)
|
2,46% |
2,59% |
|
ROA (Net Profit / Asset)
|
3,72% |
4,05% |
|
ROE (Net Profit / Equities)
|
6,88% |
7,17% |
|
Rate of Dividend
|
18,2% |
15,6% |
|
|
|